|1.||Sengupta, Krishanu: 2 articles (01/2010 - 01/2008)|
|2.||Raychaudhuri, Siba P: 2 articles (01/2010 - 01/2008)|
|3.||Krishnaraju, Alluri V: 1 article (01/2010)|
|4.||Mishra, Artatrana: 1 article (01/2010)|
|5.||Raychaudhuri, Smriti K: 1 article (01/2010)|
|6.||Vishal, Amar A: 1 article (01/2010)|
|7.||Trimurtulu, Golakoti: 1 article (01/2010)|
|8.||Sarma, Kadainti V S: 1 article (01/2010)|
|9.||Mishra, Simanchala: 1 article (01/2008)|
|10.||Alluri, Krishnaraju V: 1 article (01/2008)|
01/01/2010 - "Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study."
01/01/2008 - "A 90-day, double-blind, randomized, placebo-controlled study was conducted to evaluate the efficacy and safety of 5-Loxin in the treatment of osteoarthritis (OA) of the knee. "
01/01/2008 - "A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee."
01/01/2008 - "At the end of the study, both doses of 5-Loxin conferred clinically and statistically significant improvements in pain scores and physical function scores in OA patients. "
01/01/2008 - "5-Loxin reduces pain and improves physical functioning significantly in OA patients; and it is safe for human consumption. "
01/01/2008 - "Interestingly, significant improvements in pain score and functional ability were recorded in the treatment group supplemented with 250 mg 5-Loxin as early as 7 days after the start of treatment. "